3/21/2023 | BKCVDDEMIGPV | Market Commentary: Junk bonds surge pre-Fed; First Republic gains; Medline gains; DISH improves
|
2/2/2023 | BKCVDDEMIGPV | Market Commentary: Uniti accelerates pricing; junk secondary rips; DISH, Citrix hit new heights; Medline up
|
1/10/2023 | BKCVDDEMIGPV | Market Commentary: Venture Global drives by junkland; Transocean at a premium; Medline rally pauses
|
1/3/2023 | BKCVDDEMIGPV | Market Commentary: Ford HY benchmark offering prices, outstanding notes active, unchanged; Medline higher
|
12/9/2022 | BKCVDDEMIGPV | Market Commentary: Junk primary quiet on Friday; Chart holds premium; Navacord tucked away; Medline active
|
11/28/2022 | BKCVDDEMIGPV | Market Commentary: Secondary gives back gains; Carnival under pressure; Medline falls; Wynn Macau lower
|
11/23/2022 | BKCVDDEMIGPV | Market Commentary: Junk secondary extends gains; AMC in focus; Medline uptrend continues; Citrix adds
|
11/22/2022 | BKCVDDEMIGPV | Market Commentary: Rakuten prices in junkland, up on break; Sabre gains continue; Citrix regains 87-handle
|
9/16/2022 | BKCVDDEMIGPV | Market Commentary: Citrix, Tellurian on deck; NCR plunges in junkland; Medline weaker; Royal Caribbean sinks
|
9/6/2022 | BKCVDDEMIGPV | Market Commentary: Junk opens with gains, closes with losses; ADT jumps; Medline higher; Charter weaker
|
5/23/2022 | BKCVDDEMIGPV | Market Commentary: Secondary firms as primary idles; Medline, athenahealth lifted; cruise lines under pressure
|
5/2/2022 | BKCVDDEMIGPV | Market Commentary: Carvana improves; Medline hits new low; Springs Window sinks
|
4/12/2022 | BKCVDDEMIGPV | Market Commentary: Oldcastle on deck in junkland; Medline erases losses; CommScope under pressure
|
4/11/2022 | BKCVDDEMIGPV | Market Commentary: Primary quiet; selling pressure continues in secondary; Medline hits new low
|
2/14/2022 | BKCVDDEMIGPV | Market Commentary: Norwegian sinks in heavy market; Medline hits new low; Lumen, Goodyear down post-earnings
|
1/25/2022 | BKCVDDEMIGPV | Market Commentary: ION on tap; junk secondary weaker; Oxford outperforms; Medline gains; Netflix active
|
10/1/2021 | BKCVDDEMIGPV | Market Commentary: Domtar prices; Medline tranches mixed; Exeter at a premium; ConvaTec lags in junk secondary
|
9/30/2021 | BKCVDDEMIGPV | Market Commentary: Medline deal leads $9.95 billion Thursday HY primary; LSB, New Enterprise on 101-handle
|
9/29/2021 | BKCVDDEMIGPV | Market Commentary: Medline looms on busy HY calendar; Grifols, Rockcliff, HealthEquity move up; Uniti lags
|
9/27/2021 | BKCVDDEMIGPV | Market Commentary: Medline on deck; forward calendar grows; Altice lags; Blackstone flat; Consensus Cloud outperforms
|
9/27/2021 | BKDDHY | S&P rates Medline notes B+, B-
|